SEC Tracker
Get the app

ARCA biopharma ORKA

ARCA biopharma, Inc. and Potens Partners LLC entered into an Office Lease Agreement.

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
  • Signs a material agreement (1.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when ARCA biopharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. CytomX Therapeutics CTMX public float $372M, Jun 30, 2025
  2. Cronos Group CRON public float $380M, Jun 30, 2025
  3. REGENXBIO RGNX public float $385M, Jun 30, 2025
  4. Capricor Therapeutics CAPR public float $399M, Jun 30, 2025
  5. Cryoport CYRX public float $400M, Jun 30, 2025